Can Lexapro (Escitalopram) Cause Overactive Bladder Symptoms?
Yes, escitalopram can cause urinary incontinence and bladder dysfunction, though this is an uncommon adverse effect that occurs more frequently in elderly patients and those with pre-existing urinary outflow conditions.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information for Lexapro does not list overactive bladder symptoms among its common adverse reactions in the standardized clinical trial data. 1 However, the label does not comprehensively capture all post-marketing reports or rare adverse effects that may occur in clinical practice.
Clinical Research Evidence
Incidence and Risk
SSRIs as a class, including escitalopram, are associated with an increased risk of urinary incontinence. A large retrospective cohort study of 13,531 SSRI users found that SSRI exposure increased the incidence density ratio for urinary incontinence to 1.75 (95% CI 1.56–1.97), resulting in approximately 14 extra cases per 1,000 patients treated per year. 2
Elderly patients face substantially higher risk, with approximately 60 extra cases of urinary incontinence per 1,000 patients per year in this population. 2
The adjusted relative risk for urinary incontinence due to SSRI use was 1.61 (95% CI 1.42–1.82). 2
Mechanism and Clinical Presentations
Escitalopram can cause acute urinary retention (AUR), particularly in elderly men with known or latent benign prostatic hyperplasia. Multiple case reports document AUR developing after escitalopram initiation at standard doses, with resolution following drug discontinuation. 3, 4
The mechanism involves serotonergic effects on bladder function. Serotonin modulates both bladder storage and voiding reflexes through central and peripheral pathways. 2, 5
Escitalopram may disrupt the normal pressure relationship between bladder and urethra, leading to either increased intravesical pressure (causing urgency and frequency) or decreased outlet resistance (causing incontinence). 5
Contradictory Evidence
- One animal study suggests escitalopram may actually improve OAB symptoms in a rat model of depression-induced overactive bladder, showing improvements in bladder capacity and inter-contraction intervals. 6 However, this finding in a disease model of co-occurring depression and OAB does not negate the drug's potential to cause urinary symptoms in humans without this specific pathophysiology.
Clinical Implications and Risk Stratification
High-Risk Populations Requiring Caution
Elderly patients (age >65 years) have 4-fold higher risk of developing urinary symptoms. 2
Men with known or latent benign prostatic hyperplasia are at particular risk for acute urinary retention. 3
Patients with pre-existing marginal urinary outflow may decompensate with escitalopram initiation. 3
Monitoring Recommendations
Screen for baseline urinary symptoms before initiating escitalopram, particularly in elderly patients and men with prostatic symptoms. 3, 4
Counsel patients about the possibility of new-onset urinary urgency, frequency, or incontinence, especially during the first weeks of therapy. 2, 5
If urinary retention or incontinence develops, consider escitalopram as a potential cause even if other medications are present, as it is frequently overlooked. 4
Discontinuation of escitalopram typically resolves urinary symptoms within days, though some cases may require emergent urological intervention. 3, 4
Common Pitfalls to Avoid
Do not assume anticholinergics or antihistamines are always the culprit when urinary retention develops in patients on multiple medications—SSRIs including escitalopram should be considered. 4
Do not dismiss patient reports of new urinary symptoms as unrelated to escitalopram simply because it is not listed as a common adverse effect in the package insert. 2, 5
Do not continue escitalopram in patients who develop acute urinary retention without first attempting discontinuation, as this may prevent unnecessary invasive procedures. 3